These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2428124)

  • 1. A two-site, monoclonal antibody-based immunoassay for von Willebrand factor--demonstration that vWF function resides in a conformational epitope.
    Chand S; McCraw A; Hutton R; Tuddenham EG; Goodall AH
    Thromb Haemost; 1986 Jun; 55(3):318-24. PubMed ID: 2428124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
    Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
    Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding.
    Fujimura Y; Miyata S; Nishida S; Miura S; Kaneda M; Yoshioka A; Fukui H; Katayama M; Tuddenham EG; Usami Y
    Thromb Haemost; 1992 Oct; 68(4):464-9. PubMed ID: 1280375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
    Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
    J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a monoclonal antibody to identify patients with type I and type II von Willebrand's disease.
    Hall JD; Willis DW; Evatt BL; Jackson DW
    Thromb Haemost; 1987 Jun; 57(3):332-6. PubMed ID: 3116703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
    Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on aggregation of platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Tatewaki W; Hanano M; Nagayama R; Shibata A
    Thromb Haemost; 1986 Jun; 55(3):338-41. PubMed ID: 3018956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor.
    Vanhoorelbeke K; Cauwenberghs N; Vauterin S; Schlammadinger A; Mazurier C; Deckmyn H
    Thromb Haemost; 2000 Jan; 83(1):107-13. PubMed ID: 10669163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems.
    Favaloro EJ; Henniker A; Facey D; Hertzberg M
    Thromb Haemost; 2000 Oct; 84(4):541-7. PubMed ID: 11057847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor.
    Benson RE; Catalfamo JL; Dodds WJ
    J Lab Clin Med; 1992 Apr; 119(4):420-7. PubMed ID: 1583394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.